Эволюция лечения рака тела матки

Автор: Нечушкина Валентина Михайловна, Морхов Константин Юрьевич, Кузнецов Виктор Васильевич

Журнал: Злокачественные опухоли @malignanttumors

Статья в выпуске: 4S1 (21), 2016 года.

Бесплатный доступ

Статья посвящена эволюции хирургического, лучевого и лекарственного лечения рака тела матки на протяжении последних 20 лет. В ней обсуждаются результаты ключевых исследований по данной проблеме, изменившие подходы к лечению этой патологии.

Рак тела матки, лимфодиссекция, лапароскопические операции, лучевая терапия, химиотерапия

Короткий адрес: https://readera.ru/140223018

IDR: 140223018   |   DOI: 10.18027/2224-5057-2016-4s1-92-98

Список литературы Эволюция лечения рака тела матки

  • Boronow, R. C. Endometrial cancer: not a benign disease/R. C. Boronow//Obstet. Gynecol.-1976.-Vol. 47, N5.-P. 630634.
  • Childers, J. M. Combined laparoscopic and vaginal surgery for the management of two cases of stage I endometrial cancer/J. M. Childers, E. A. Surwit//Gynecol. Oncol.-1992.-Vol. 45, N1.-P. 46-51.
  • Cost and quality-of-life analyses of surgery for early endometrial cancer: laparotomy versus laparoscopy/N. M. Spirtos, J. B. Schlaerth, G. M. Gross et al.//Am. J. Obstet. Gynecol.-1996.-Vol. 174, N6.-P. 1795-1799.
  • Lymph node yield from laparoscopic lymphadenectomy in cervical cancer: a comparative study/J. M. Fowler, J. R. Carter, J. W. Carlson et al.//Gynecol. Oncol.-1993.-Vol. 51, N2.-P. 187-192.
  • Phase III trial of laparoscopy versus laparotomy for surgical resection and comprehensive surgical staging of uterine cancer: a Gynecologic Oncology Group study/J. Walker, R. Mannel, M. Piedmonte et al.//Gynecol. Oncol.-2006.-Vol. 101 (suppl. 1).-P. 11-12.
  • Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 Study/J. Walker, M. Piedmonte, N. Spirtos et al.//J. Clin. Oncol.-2012.-Vol. 30, N7.-P. 695-700.
  • Бохман, Я. В. Метастазы рака матки/Я. В. Бохман.-Л.: Медицина, 1976.-159 с.
  • Surgical pathologic spread patterns of endometrial Cancer. A Gynecologic Oncology Group Study/W. T. Creasman, C. P. Morrow, B. N. Bundy et al.//Cancer.-1987.-Vol. 60, N8 (suppl.).-P. 2035-2041.
  • Lymphadenectomy in endometrioid uterine Cancer staging: how many lymph nodes are enough? A study of 11,443 patients/J. K. Chan, R. Urban, M. K. Cheung et al.//Cancer.-2007 -Vol. 109, N12.-P. 2454-2460.
  • Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study/ASTEC study group, Kitchener H., Swart A. M. et al.//Lancet.-2009.-Vol. 373, N9658.-P. 125-136.
  • Creasman, W. T. The current status of lymphadenectomy in the management of endometrial cancer/W. T. Creasman//Womens Health (Lond. Engl).-2011.-Vol. 7, N1.-P. 33-35.
  • Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis/Y. Todo, H. Kato, M. Kaneuchi et al.//Lancet.-2010.-Vol. 375, N9721.-P. 1165-1172.
  • Therapeutic impact of para-aortic lymphadenectomy in patients with high-risk, early stage and advanced stage endometrial carcinoma/Y. Suzuki, Y. Todo, K. Okamoto et al.//Proceedings of the 13th Biennial Meeting of International Gynecologic Cancer Society, Prague, 23-26 Oct 2010.-Abs. 1433.
  • Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial/P. Benedetti Panici, S. Basile, F. Maneschi et al.//J. Natl. Cancer Inst.-2008.-Vol. 100, N23.-P. 1707-1716.
  • The influence of radiation modality and lymph node dissection on survival in early-stage endometrial cancer/J. P. Chino, E. Jones, A. Berchuk et al.//Int. J. Radiat. Oncol. Biol. Phys.-2012-Vol. 82, N5.-P. 1872-1879.
  • ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up/N. Colombo, C. Creutzberg, F. Amant et al.//Radiother. Oncol.-2015.-Vol. 117, N3.-P. 559-581.
  • Amant, F. Cancer of the corpus uteri/F. Amant, M. R. Mirza, C. L. Creutzberg//Int. J. Gynaecol. Obstet.-2012.-Vol. 119, Suppl. 2.-P. S110-S117.
  • Resection of lymph node metastases influences survival in stage IIIC endometrial cancer/L. J. Havrilesky, J. Cragun, B. Calingaert et al.//Gynecol. Oncol.-2005.-Vol. 99, N3.-P. 689-695.
  • Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer/J. M. Cragun, L. J. Havrilesky, B. Calingaert et al.//J. Clin. Oncol.-2005.-Vol. 23, N16.-P. 3668-3675.
  • Pelvic lymphadenectomy in the surgical treatment of endometrial cancer/F. Girardi, E. Petru, M. Heydarfadai et al.//Gynecol. Oncol.-1993.-Vol. 49, N2.-P. 177-180.
  • Corpus: epithelial tumors/D. S. McMeekin, C. Yashar, S. Campos, R. J. Zaino//Principles and Practice of Gynecologic Oncology/R. R. Barakat, A. Berchuk, M. Markman, M. E. Randall (eds.).-6th ed.-: Wolters Kluwer/Lippincott Williams & Wilkins, 2013.-P. 661-714.
  • Surgery and postoperative radiotherapy versus surgery alone for patients with stage 1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. PostOperative Radiation Therapy in Endometrial Carcinoma/C. L. Creutzberg, W. L. van Putten, P. C. Koper et al.//Lancet.-2000 -Vol. 355.-P. 1404-1411.
  • A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study/H. M. Keys, J. A. Roberts, V. L. Brunetto et al.//Gynecol. Oncol.-2004.-Vol. 92, N3.-P. 744-751.
  • Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis/ASTEC/EN.5 Study Group, P. Blake, A. M. Swart et al.//Lancet.-2009.-Vol. 373, N9658.-P. 137-146.
  • Johnson N., Cornes P. Survival and recurrent disease after postoperative radiotherapy for early endometrial cancer: systematic review and meta-analysis//BJOG.-2007.-Vol. 114, N11.-P. 1313-1320.
  • Long-term outcomes after pelvic radiation for early-stage endometrial cancer/M. Onsrud, M. Cvancarova, T. P. Hellebust et al.//J. Clin. Oncol.-2013.-Vol. 31, N31.-P. 3951-3956.
  • Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients/J. Aalders, V. Abeler, P. Kolstad, M. Onsrud//Obstet. Gynecol.-1980.-Vol. 56, N4.-P. 419-427.
  • Адъювантная дистанционная лучевая терапия при раке тела матки I -II стадий/В. М. Нечушкина, К. Ю. Морхов, B. В. Кузнецов, А. В. Егорова//Онкогинекология.-2014.-№ 4.-С. 37-44.
  • Нечушкина, В. М. Рак тела матки (факторы прогноза и тактика лечения): дис.. д-ра мед. наук: 14.01.12/Нечушкина Валентина Михайловна.-М., 2013.-445 с.
  • Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis/A. Kong, N. Johnson, H. C. Kitchener, T. A. Lawrie//J. Natl. Cancer Inst.-2012.-Vol. 104, N21.-P. 1625-1634.
  • Comparison of clinical and surgical staging in patients with endometrial carcinoma/T. A. Cowles, J. F. Magrina, B. J. Masterson, C. V. Capen//Obstet. Gynecol.-1985.-Vol. 66, N3.-P. 413-416.
  • Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study/R. C. Boronow, C. P. Morrow, W. T. Creasman et al.//Obstet. Gynecol.-1984.-Vol. 63, N6.-P. 825-832.
  • Tumor size in endometrial cancer: a prognostic factor for lymph node metastasis/J. C. Schink, J. R. Lurain, C. B. Wallemark, J. S. Chmiel//Obstet. Gynecol.-1987.-Vol. 70, N2.-P. 216-219.
  • Conservative management of stage I endometrial carcinoma after surgical staging/J. M. Straughn, Jr., W. K. Huh, F. J. Kelly et al.//Gynecol. Oncol.-2002.-Vol. 84, N2.-P. 194-200.
  • Stage IC adenocarcinoma of the endometrium: survival comparisons of surgically staged patients with and without adjuvant radiation therapy/J. M. Straughn, W. K. Huh, J. W. Orr, Jr. et al.//Gynecol. Oncol.-2003.-Vol. 89, N2.-P. 295-300.
  • Vaginal brachytherapyversus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial/R. A. Nout, V. T. H. B. M. Smit, H. Putter et al.//Lancet.-2010.-Vol. 375, N9717.-P. 816-823.
  • Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial/R. Maggi, A. Lissoni, F. Spina et al.//Br. J. Cancer.-2006.-Vol. 95, N3.-P. 266-271.
  • Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate-and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study/N. Susumu, S. Sagae, Y. Udagawa et al.//Gynecol. Oncol.-2008.-Vol. 108, N1.-P. 226-233.
  • Randomized phase III trial of WART versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a GOG study/M. Randall, V. Filiaci, H. Muss et al.//J. Clin. Oncol.-2006.-Vol. 24, N1.-P. 36-44.
  • Phase III randomized trial of doxorubicin + cisplatin versus doxorubicin + 24-h paclitaxel + filgrastim in endometrial carcinoma: a Gynecologic Oncology Group study/G. F. Fleming, V. L. Filiaci, R. C. Bentley et al.//Ann. Oncol.-2004.-Vol. 15, N8.-P. 1173-1178.
  • Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study/G. F. Fleming, V. L. Brunetto, D. Cella et al.//J. Clin. Oncol.-2004.-Vol. 22, N11.-P. 2159-2166.
  • Randomized phase III noninferiority trial of first line chemotherapy for metastatic recurrent endometrial carcinoma: a Gynecologic Oncology Group study/D. Miller, V. Filiaci, G. Fleming et al.//Gynecol. Oncol.-2012.-Vol. 125, N3.-P. 771.
Еще
Статья научная